Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2005, Vol. 6 Issue (1): 57-60    DOI: 10.1631/jzus.2005.B0057
Biomedicine     
Treatment of 140 cerebral palsied children with a combined method based on traditional Chinese medicine (TCM) and western medicine
ZHOU Xue-juan, ZHENG Kun
Affiliated Children’s Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Objective: To observe and evaluate a method that is effective and practical for treatment of cerebral palsied (CP) children in China. Method: The patient’s age and disease type and individual specific conditions were considered in choosing therapy methods accordingly: Chinese herbs, acupuncture, auricular seed pressure, point finger pressing, massage, orthopedic hand manipulation, physiotherapy, occupational therapy, language therapy, etc. Meanwhile we created a new CP treatment model that combines hospitalized treatment with family therapy. Results: The majority of CP patients improved greatly in motor and social adaptation capacities after treatment. Wilcoxon paired rank sum test analysis showed that there were significant differences between the data before and after treatment (P<0.01). Conclusion: This combined therapy method, based on traditional Chinese medicine and western medicine plus family supplemental therapy, is an effective and practical treatment strategy for CP children in China.

Key wordsTraditional Chinese medicine (TCM) combined with western medicine      Therapy      Childhood cerebral palsy     
Received: 25 December 2003     
CLC:  R742.3  
Cite this article:

ZHOU Xue-juan, ZHENG Kun. Treatment of 140 cerebral palsied children with a combined method based on traditional Chinese medicine (TCM) and western medicine. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2005, 6(1): 57-60.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.2005.B0057     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2005/V6/I1/57

[1] Meng-wen Zhang, Kenji Fujiwara, Xu Che, Shu Zheng, Lei Zheng. DNA methylation in the tumor microenvironment[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(5): 365-372.
[2] Ming Zhao, Xian-feng Ding, Jian-yu Shen, Xi-ping Zhang, Xiao-wen Ding, Bin Xu. Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(1): 15-26.
[3] Chun-xi Wang, Shu-li Guo, Li-na Han. Successful treatment of accessory breast cancer with endocrine therapy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2017, 18(1): 70-75.
[4] Yang Guo, Bo Chen, Li-jun Chen, Chun-feng Zhang, Charlie Xiang. Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(11): 831-841.
[5] Xu-wei Luo, Kang Liu, Zhu Chen, Ming Zhao, Xiao-wei Han, Yi-guang Bai, Gang Feng. Adenovirus-mediated GDF-5 promotes the extracellular matrix expression in degenerative nucleus pulposus cells[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(1): 30-42.
[6] Xiao-peng Lan, You-gen Chen, Zheng Wang, Chuan-wei Yuan, Gang-gang Wang, Guo-liang Lu, Shao-wei Mao, Xun-bo Jin, Qing-hua Xia. Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(9): 743-756.
[7] Hui-ying Wang, Yi-hong Shen, Xu-yan Yang, Lan-fang Tang, Jian-ying Zhou, on behalf of the Zhejiang Provincial Academy of Allergy . Diagnosis and treatment of allergic diseases in Zhejiang Province: a cross-sectional survey[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(7): 640-650.
[8] Xinguo Jiang. Macrophage-produced IL-10 limits the chemotherapy efficacy in breast cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(1): 44-45.
[9] Wei Wang, Yun-ping Luo. MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2015, 16(1): 18-31.
[10] You-yun Zhang, Zhi-gen Zhang, Yan-lan Yu, Yi-cheng Chen, Kang-xin Ni, Ming-chao Wang, Wei-ping Zhao, Faisal Rehman, Shaw P. Wan, Gong-hui Li. Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(8): 756-760.
[11] Chai-Hong Yeong, Mu-hua Cheng, Kwan-Hoong Ng. Therapeutic radionuclides in nuclear medicine: current and future prospects[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(10): 845-863.
[12] Xinguo Jiang. Harnessing the immune system for the treatment of breast cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 1-15.
[13] Hai-ying Xu, Yi-zhou Xu, Feng Ling, Zhong Yu, Jun Yang, Xu Duan, Bei Wang, Jin-yu Huang. Application of CRT-D in a Marfan syndrome patient with chronic heart failure accompanied by ventricular tachycardia and ventricular fibrillation[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(8): 759-762.
[14] Yan Jiang, Jing Zhao, Hui-jing Qi, Xiao-lin Li, Shi-rong Zhang, Daniel W. Song, Chi-yang Yu, Jian-gang Gao. Accelerated ovarian aging in mice by treatment of busulfan and cyclophosphamide[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(4): 318-324.
[15] Wen-hua Ruan, Mei-li Huang, Xiao-lei He, Feng Zhang, Hai-biao Tao. Effects of Huangqi and bear bile on recurrent parotitis in children: a new clinical approach[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2013, 14(3): 253-258.